- Home
- TARA vs TTEC Comparison
TARA vs TTEC Comparison
Compare TARA & TTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- TTEC
- Stock Information
- Founded
- TARA N/A
- TTEC 1982
- Country
- TARA United States
- TTEC United States
- Employees
- TARA N/A
- TTEC N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- TTEC Retail: Computer Software & Peripheral Equipment
- Sector
- TARA Health Care
- TTEC Technology
- Exchange
- TARA Nasdaq
- TTEC Nasdaq
- Market Cap
- TARA 196.8M
- TTEC 183.7M
- IPO Year
- TARA N/A
- TTEC 1996
- Fundamental
- Price
- TARA $5.20
- TTEC $3.40
- Analyst Decision
- TARA Strong Buy
- TTEC Hold
- Analyst Count
- TARA 6
- TTEC 2
- Target Price
- TARA $19.80
- TTEC $3.50
- AVG Volume (30 Days)
- TARA 504.0K
- TTEC 259.0K
- Earning Date
- TARA 11-03-2025
- TTEC 11-06-2025
- Dividend Yield
- TARA N/A
- TTEC N/A
- EPS Growth
- TARA N/A
- TTEC N/A
- EPS
- TARA N/A
- TTEC N/A
- Revenue
- TARA N/A
- TTEC $2,144,663,000.00
- Revenue This Year
- TARA N/A
- TTEC N/A
- Revenue Next Year
- TARA N/A
- TTEC $0.47
- P/E Ratio
- TARA N/A
- TTEC N/A
- Revenue Growth
- TARA N/A
- TTEC N/A
- 52 Week Low
- TARA $2.21
- TTEC $2.67
- 52 Week High
- TARA $10.48
- TTEC $5.86
- Technical
- Relative Strength Index (RSI)
- TARA 57.60
- TTEC 44.32
- Support Level
- TARA $4.96
- TTEC $3.40
- Resistance Level
- TARA $5.32
- TTEC $3.65
- Average True Range (ATR)
- TARA 0.30
- TTEC 0.16
- MACD
- TARA -0.11
- TTEC -0.01
- Stochastic Oscillator
- TARA 15.55
- TTEC 27.25
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About TTEC TTEC Holdings Inc.
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.